Bristol-Myers Squibb buy Truist Financial Co.
Start price
06.10.23
/
50%
€53.50
Target price
06.10.24
€79.27
Performance (%)
-8.08%
End price
07.10.24
€49.18
Summary
This prediction ended on 07.10.24 with a price of €49.18. With a performance of -8.08%, the BUY prediction by Truist_Financial_Co_ finished with a loss. Truist_Financial_Co_ has a follow-up prediction for Bristol-Myers Squibb where he still thinks Bristol-Myers Squibb is a Buy. Dividends of €2.20 are taken into consideration when calculating the performance. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bristol-Myers Squibb | -0.290% | -0.290% | -15.939% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb (NYSE: BMY) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $84.00 price target on the stock.
Ratings data for BMY provided by MarketBeat
In the thread Trading Bristol-Myers Squibb
Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Truist_Financial_Co_ for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€55.56
08.01.25
08.01.25
€63.06
08.01.26
08.01.26
-19.27%
10:47
10:47
Stopped prediction by Truist_Financial_Co_ for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€55.60
15.09.23
15.09.23
€78.67
15.09.24
15.09.24
-20.88%
16.09.24
16.09.24